SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.

Income Statement Shanghai MicroPort MedBot (Group) Co., Ltd.

Equities

2252

CNE100004QP1

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 09:08:58 10/09/2024 BST			5-day change	1st Jan Change
6.300 ^HKD	-3.23%		-9.09%	-69.78%

08-28	Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
08-14	Shanghai MicroPort MedBot Co., Ltd. Announces Management Changes	CI

635.IhY_EYWd7YBwXM9nq-F__Hmu8k0qVGhPO7wtDAIu9vw.aXNsXdLHiPEcO6om8rJIpjzHpj5bASQ8SNQAaEdcn5lHRk9a4qir6xUKig

Published financial data: SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	-	-	2.15M	21.6M	105M
Total Revenues	-	-	2.15M	21.6M	105M
Cost of Goods Sold, Total	-	-	1.23M	15.04M	89.9M
Gross Profit	-	-	919K	6.56M	14.69M
Selling General & Admin Expenses, Total	10.66M	29.58M	187M	355M	365M
R&D Expenses	61.88M	135M	393M	756M	569M
Other Operating Expenses	-2.21M	-2.36M	-8.74M	-6.78M	-18.04M
Other Operating Expenses, Total	70.34M	163M	571M	1.1B	916M
Operating Income	-70.34M	-163M	-570M	-1.1B	-901M
Interest Expense, Total	-520K	-49.13M	-5.29M	-11.13M	-18.41M
Interest And Investment Income	1.07M	8.09M	22.07M	26.65M	8.87M
Net Interest Expenses	546K	-41.04M	16.78M	15.53M	-9.53M
Income (Loss) On Equity Invest.	-	-1.68M	-27.38M	-39.66M	-29.8M
Currency Exchange Gains (Loss)	1K	-676K	-9.11M	2.04M	201K
Other Non Operating Income (Expenses)	-11K	-3.31M	45.38M	-27.22M	-42.71M
EBT, Excl. Unusual Items	-69.8M	-209M	-544M	-1.15B	-983M
Other Unusual Items	-	-	-40.53M	-	-40.45M
EBT, Incl. Unusual Items	-69.8M	-209M	-585M	-1.15B	-1.02B
Earnings From Continuing Operations	-69.8M	-209M	-585M	-1.15B	-1.02B
Net Income to Company	-69.8M	-209M	-585M	-1.15B	-1.02B
Minority Interest	-	416K	1.59M	6.48M	11.36M
Net Income - (IS)	-69.8M	-209M	-583M	-1.14B	-1.01B
Preferred Dividend and Other Adjustments	-	-5.98M	-	-	-
Net Income to Common Incl Extra Items	-69.8M	-203M	-583M	-1.14B	-1.01B
Net Income to Common Excl. Extra Items	-69.8M	-203M	-583M	-1.14B	-1.01B
Per Share Items
Net EPS - Basic	-0.11	-0.27	-0.63	-1.19	-1.06
Basic EPS - Continuing Operations	-0.11	-0.27	-0.63	-1.19	-1.06
Basic Weighted Average Shares Outstanding	618M	756M	920M	959M	959M
Net EPS - Diluted	-0.11	-0.27	-0.63	-1.19	-1.06
Diluted EPS - Continuing Operations	-0.11	-0.27	-0.63	-1.19	-1.06
Diluted Weighted Average Shares Outstanding	618M	756M	920M	959M	959M
Normalized Basic EPS	-0.07	-0.17	-0.37	-0.74	-0.63
Normalized Diluted EPS	-0.07	-0.17	-0.37	-0.74	-0.63
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	-69.22M	-161M	-563M	-1.05B	-840M
EBITA	-70.34M	-163M	-570M	-1.1B	-901M
EBIT	-70.34M	-163M	-570M	-1.1B	-901M
EBITDAR	-67.78M	-159M	-559M	-1.05B	-833M
Normalized Net Income	-43.63M	-130M	-338M	-710M	-603M
Interest on Long-Term Debt	453K	469K	5.29M	11.13M	6.97M
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	2.69M	79.19M	184M	238M
General and Administrative Expenses	9.22M	24.72M	107M	170M	126M
Research And Development Expense From Footnotes	61.88M	135M	393M	756M	569M
Net Rental Expense, Total	1.44M	2.16M	3.38M	6.74M	7.04M
Imputed Operating Lease Interest Expense	-	53.59M	1.27M	2.82M	2.54M
Imputed Operating Lease Depreciation	-	-51.43M	2.1M	3.92M	4.5M
Stock-Based Comp., R&D Exp. (Total)	-	-	56.22M	89.9M	72.36M
Stock-Based Comp., S&M Exp. (Total)	-	-	12.69M	18.02M	12.49M
Stock-Based Comp., G&A Exp. (Total)	-	-	22.28M	29M	27.03M
Stock-Based Comp., Other (Total)	2.98M	15.78M	-	-	-
Total Stock-Based Compensation	2.98M	15.78M	91.2M	137M	112M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	54.71M	1.5B	1.94B	748M	508M
Total Cash And Short Term Investments	54.71M	1.5B	1.94B	748M	508M
Accounts Receivable, Total	-	-	87K	-	4.97M
Other Receivables	16K	11.16M	7.96M	73.33M	36.99M
Total Receivables	16K	11.16M	8.04M	73.33M	41.96M
Inventory	-	-	110M	250M	230M
Other Current Assets, Total	1.6M	6.57M	35.48M	27.05M	14.87M
Total Current Assets	56.33M	1.52B	2.09B	1.1B	794M
Gross Property Plant And Equipment	17.93M	46.41M	403M	624M	569M
Accumulated Depreciation	-3.49M	-7.7M	-42.48M	-133M	-202M
Net Property Plant And Equipment	14.44M	38.71M	361M	492M	367M
Long-term Investments	-	124M	260M	285M	215M
Goodwill	-	1.48M	1.48M	1.48M	1.48M
Other Intangibles, Total	337K	565K	3.07M	7.05M	9.54M
Other Long-Term Assets, Total	7.33M	24.75M	71.98M	46.44M	40.62M
Total Assets	78.44M	1.7B	2.79B	1.93B	1.43B
Liabilities
Accounts Payable, Total	12.13M	28.34M	83.6M	125M	74.25M
Accrued Expenses, Total	5.04M	13.92M	39.41M	64.09M	78.66M
Short-term Borrowings	526K	356K	356K	356K	356K
Current Portion of Long-Term Debt	-	-	-	-	375M
Current Portion of Leases	5.57M	7.29M	52.86M	58.22M	47.88M
Unearned Revenue Current, Total	-	-	-	8.49M	11.12M
Other Current Liabilities	18.02M	179M	58.24M	69.61M	97.65M
Total Current Liabilities	41.3M	229M	234M	325M	685M
Long-Term Debt	-	-	-	33.1M	99.7M
Long-Term Leases	6.35M	11.59M	152M	129M	72.51M
Unearned Revenue Non Current	4.38M	22.4M	15.05M	34.8M	68.59M
Other Non Current Liabilities	-	-	397K	397K	82K
Total Liabilities	52.02M	263M	402M	522M	926M
Common Stock, Total	35.08M	900M	959M	959M	959M
Additional Paid In Capital	-	619M	2.01B	2.01B	2.01B
Retained Earnings	-144M	-135M	-718M	-1.86B	-2.87B
Comprehensive Income and Other	136M	59.17M	146M	311M	425M
Total Common Equity	26.41M	1.44B	2.39B	1.42B	519M
Minority Interest	-	-1.4M	-2.99M	-9.78M	-17.72M
Total Equity	26.41M	1.44B	2.39B	1.41B	502M
Total Liabilities And Equity	78.44M	1.7B	2.79B	1.93B	1.43B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	618M	900M	959M	959M	959M
ECS Total Common Shares Outstanding	618M	900M	959M	959M	959M
Book Value / Share	0.04	1.6	2.5	1.48	0.54
Tangible Book Value	26.07M	1.44B	2.39B	1.41B	508M
Tangible Book Value Per Share	0.04	1.6	2.49	1.47	0.53
Total Debt	12.44M	19.24M	205M	220M	596M
Net Debt	-42.26M	-1.48B	-1.74B	-528M	88.09M
Debt Equivalent Oper. Leases	11.55M	17.28M	27M	53.9M	56.29M
Minority Interest, Total (Incl. Fin. Div)	-	-1.4M	-2.99M	-9.78M	-17.72M
Equity Method Investments, Total	-	85.43M	124M	175M	148M
Account Code - Inventory Valuation	-	5	6	6	6
Inventories - Raw Materials, Total	-	-	95.38M	162M	111M
Inventories - Work In Process, Total	-	-	7.17M	18.26M	54.02M
Inventories - Finished Goods, Total	-	-	7.33M	70.2M	63.74M
Inventories - Others	-	-	-	25K	407K
Machinery, Total	7.27M	12.09M	100M	239M	291M
Full Time Employees	-	-	898	1.23K	646

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-69.8M	-209M	-583M	-1.14B	-1.01B
Depreciation & Amortization - CF	2.94M	4.23M	34.9M	98.89M	109M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	173K
Depreciation & Amortization, Total	2.94M	4.23M	34.9M	98.89M	109M
Amortization of Deferred Charges, Total - (CF)	203K	229K	474K	1.81M	2.66M
(Gain) Loss From Sale Of Asset	-	10K	-	-1.92M	951K
(Gain) Loss on Sale of Investments - (CF)	-	3.25M	-45.52M	26.98M	42.52M
(Income) Loss On Equity Investments - (CF)	-	1.68M	27.38M	39.66M	29.8M
Stock-Based Compensation (CF)	2.98M	15.78M	91.2M	137M	112M
Other Operating Activities, Total	-525K	48.71M	14.72M	3.23M	43.4M
Change In Accounts Receivable	-942K	-16.1M	-8.21M	-65.97M	39.47M
Change In Inventories	-	-	-110M	-141M	25.37M
Change In Accounts Payable	16.87M	33.97M	82.09M	85.1M	5.86M
Change in Unearned Revenues	2.5M	18.02M	-7.45M	18.07M	31.66M
Change in Other Net Operating Assets	-2.91M	-3.94M	-37.25M	39.15M	1.66M
Cash from Operations	-48.7M	-103M	-540M	-898M	-568M
Capital Expenditure	-3.66M	-14.55M	-131M	-188M	-64.98M
Sale of Property, Plant, and Equipment	-	-	-	-	7.67M
Sale (Purchase) of Intangible assets	-9K	-457K	-2.98M	-6.54M	-1.47M
Investment in Marketable and Equity Securities, Total	-	-	-263M	-70.21M	-
Other Investing Activities, Total	30.39M	3K	-	-2.8M	399K
Cash from Investing	26.72M	-15.01M	-397M	-268M	-58.38M
Short Term Debt Issued, Total	170K	-	-	20M	-
Long-Term Debt Issued, Total	-	-	-	33.1M	437M
Total Debt Issued	170K	-	-	53.1M	437M
Short Term Debt Repaid, Total	-10M	-3.67M	-	-20M	-
Long-Term Debt Repaid, Total	-	-4.45M	-18.68M	-51.83M	-37.83M
Total Debt Repaid	-10M	-8.12M	-18.68M	-71.83M	-37.83M
Issuance of Common Stock	80.47M	1.57B	1.45B	-	-
Other Financing Activities, Total	644K	-466K	-39.95M	-9.21M	-13M
Cash from Financing	71.28M	1.56B	1.39B	-27.95M	386M
Foreign Exchange Rate Adjustments	-	-	-11.68M	1.38M	301K
Net Change in Cash	49.31M	1.44B	443M	-1.19B	-240M
Supplemental Items
Cash Interest Paid	9K	466K	4.57M	10.64M	17.16M
Levered Free Cash Flow	-	42.86M	-542M	-762M	-358M
Unlevered Free Cash Flow	-	73.57M	-539M	-755M	-347M
Change In Net Working Capital	-	-170M	176M	112M	-59.47M
Net Debt Issued / Repaid	-9.83M	-8.12M	-18.68M	-18.73M	399M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	-11.4	-15.84	-29.04	-33.55
Return on Total Capital	-	-13.55	-17.56	-32.47	-41.33
Return On Equity %	-	-28.52	-30.51	-60.36	-107.2
Return on Common Equity	-	-27.62	-30.39	-59.82	-104.5
Margin Analysis
Gross Profit Margin %	-	-	42.74	30.38	14.05
SG&A Margin	-	-	8.68K	1.64K	348.77
EBITDA Margin %	-	-	-26.16K	-4.88K	-803.31
EBITA Margin %	-	-	-26.5K	-5.08K	-861.5
EBIT Margin %	-	-	-26.5K	-5.08K	-861.67
Income From Continuing Operations Margin %	-	-	-27.19K	-5.31K	-978.59
Net Income Margin %	-	-	-27.11K	-5.28K	-967.74
Net Avail. For Common Margin %	-	-	-27.11K	-5.28K	-967.74
Normalized Net Income Margin	-	-	-15.74K	-3.29K	-576.59
Levered Free Cash Flow Margin	-	-	-25.23K	-3.53K	-342.41
Unlevered Free Cash Flow Margin	-	-	-25.08K	-3.49K	-331.41
Asset Turnover
Asset Turnover	-	-	0	0.01	0.06
Fixed Assets Turnover	-	-	0.01	0.05	0.24
Inventory Turnover (Average Inventory)	-	-	-	0.08	0.37
Short Term Liquidity
Current Ratio	1.36	6.62	8.93	3.38	1.16
Quick Ratio	1.33	6.59	8.31	2.52	0.8
Operating Cash Flow to Current Liabilities	-1.18	-0.45	-2.31	-2.76	-0.83
Days Outstanding Inventory (Average Inventory)	-	-	-	4.37K	974.4
Average Days Payable Outstanding	-	-	-	244.07	526.37
Long Term Solvency
Total Debt/Equity	47.12	1.33	8.58	15.65	118.74
Total Debt / Total Capital	32.03	1.32	7.9	13.53	54.28
LT Debt/Equity	24.03	0.8	6.35	11.49	34.32
Long-Term Debt / Total Capital	16.34	0.79	5.85	9.93	15.69
Total Liabilities / Total Assets	66.33	15.43	14.39	27.06	64.86
EBIT / Interest Expense	-135.26	-3.31	-107.62	-98.6	-48.96
EBITDA / Interest Expense	-129.62	-3.22	-101.03	-89.71	-43.03
(EBITDA - Capex) / Interest Expense	-136.65	-3.52	-125.78	-106.63	-46.56
Total Debt / EBITDA	-0.18	-0.12	-0.38	-0.22	-0.75
Net Debt / EBITDA	0.63	9.33	3.25	0.53	-0.11
Total Debt / (EBITDA - Capex)	-0.18	-0.11	-0.31	-0.19	-0.7
Net Debt / (EBITDA - Capex)	0.59	8.55	2.61	0.44	-0.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	904.79	384.15
Gross Profit, 1 Yr. Growth %	-	-	-	614.04	123.93
EBITDA, 1 Yr. Growth %	-	132.47	249.54	87.46	-20.32
EBITA, 1 Yr. Growth %	-	131.16	250.36	92.57	-17.86
EBIT, 1 Yr. Growth %	-	131.16	250.36	92.57	-17.84
Earnings From Cont. Operations, 1 Yr. Growth %	-	199.84	179.28	96.11	-10.71
Net Income, 1 Yr. Growth %	-	199.24	179.08	95.53	-11.2
Normalized Net Income, 1 Yr. Growth %	-	198.88	159.53	109.79	-15.06
Diluted EPS Before Extra, 1 Yr. Growth %	-	137.91	136.01	87.63	-11.2
Inventory, 1 Yr. Growth %	-	-	-	127.95	-8.37
Net Property, Plant and Equip., 1 Yr. Growth %	-	168.02	832.58	36.17	-25.34
Total Assets, 1 Yr. Growth %	-	2.07K	63.81	-30.87	-26.02
Tangible Book Value, 1 Yr. Growth %	-	5.43K	65.78	-41.01	-63.92
Common Equity, 1 Yr. Growth %	-	5.36K	65.86	-40.76	-63.36
Cash From Operations, 1 Yr. Growth %	-	111.6	424.53	66.23	-36.8
Capital Expenditures, 1 Yr. Growth %	-	297.65	800.07	43.72	-65.48
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-1.37K	40.43	-52.98
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-832.85	40	-54.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	597.48
Gross Profit, 2 Yr. CAGR %	-	-	-	-	299.86
EBITDA, 2 Yr. CAGR %	-	-	185.06	155.98	22.22
EBITA, 2 Yr. CAGR %	-	-	184.59	159.75	25.77
EBIT, 2 Yr. CAGR %	-	-	184.59	159.75	25.78
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	189.38	134.03	32.33
Net Income, 2 Yr. CAGR %	-	-	188.98	133.6	31.77
Normalized Net Income, 2 Yr. CAGR %	-	-	178.51	133.34	33.5
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	136.96	110.43	29.08
Accounts Receivable, 2 Yr. CAGR %	-	-	-	-	655.74
Inventory, 2 Yr. CAGR %	-	-	-	-	44.52
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	399.95	256.36	0.83
Total Assets, 2 Yr. CAGR %	-	-	496.61	6.42	-28.48
Tangible Book Value, 2 Yr. CAGR %	-	-	857.12	-1.11	-53.86
Common Equity, 2 Yr. CAGR %	-	-	851.9	-0.88	-53.41
Cash From Operations, 2 Yr. CAGR %	-	-	233.15	195.29	2.5
Capital Expenditures, 2 Yr. CAGR %	-	-	498.26	259.67	-29.57
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	321.57	-18.75
Unlevered Free Cash Flow, 2 Yr. CAGR %